Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/3126
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan Vlierberghe, H-
dc.contributor.authorLeroux-Roels, G-
dc.contributor.authorBourgeois, N-
dc.contributor.authorNevens, F-
dc.contributor.authorColle, I-
dc.contributor.authorHenrion, J-
dc.contributor.authorDelwaide, J-
dc.contributor.authorHorsmans, Y-
dc.contributor.authorBrenard, R-
dc.contributor.authorMichielsen, P-
dc.contributor.authorROBAEYS, Geert-
dc.contributor.authorBRUCKERS, Liesbeth-
dc.date.accessioned2007-11-26T15:34:14Z-
dc.date.available2007-11-26T15:34:14Z-
dc.date.issued1999-
dc.identifier.citationHEPATOLOGY, 30(4). p. 631A-631A-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/1942/3126-
dc.language.isoen-
dc.publisherW B SAUNDERS CO-
dc.titleDaily induction treatment with alpha 2b interferon in naive chronic hepatitis C patients results in a higher early response. A controlled multicenter randomized trial.-
dc.typeJournal Contribution-
dc.identifier.epage631A-
dc.identifier.issue4-
dc.identifier.spage631A-
dc.identifier.volume30-
local.format.pages1-
dc.description.notesBelgian Assoc Study Liver, Ghent, Belgium. Univ Hosp Gent, Ghent, Belgium. Ctr Biostat, Diepenbeek, Belgium.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000082794701879-
item.contributorVan Vlierberghe, H-
item.contributorLeroux-Roels, G-
item.contributorBourgeois, N-
item.contributorNevens, F-
item.contributorColle, I-
item.contributorHenrion, J-
item.contributorDelwaide, J-
item.contributorHorsmans, Y-
item.contributorBrenard, R-
item.contributorMichielsen, P-
item.contributorROBAEYS, Geert-
item.contributorBRUCKERS, Liesbeth-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
item.fullcitationVan Vlierberghe, H; Leroux-Roels, G; Bourgeois, N; Nevens, F; Colle, I; Henrion, J; Delwaide, J; Horsmans, Y; Brenard, R; Michielsen, P; ROBAEYS, Geert & BRUCKERS, Liesbeth (1999) Daily induction treatment with alpha 2b interferon in naive chronic hepatitis C patients results in a higher early response. A controlled multicenter randomized trial.. In: HEPATOLOGY, 30(4). p. 631A-631A.-
Appears in Collections:Research publications
Show simple item record

Page view(s)

42
checked on Nov 7, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.